R. Michael Gendreau
2023
In 2023, R. Michael Gendreau earned a total compensation of $364.9K as Chief Medical Officer at Virios Therapeutics, a 36% decrease compared to previous year.
Compensation breakdown
| Salary | $335,563 |
|---|---|
| Other | $29,379 |
| Total | $364,942 |
Gendreau received $335.6K in salary, accounting for 92% of the total pay in 2023.
Gendreau also received $29.4K in other compensation.
Rankings
In 2023, R. Michael Gendreau's compensation ranked 2,159th out of 2,647 executives tracked by ExecPay. In other words, Gendreau earned more than 18.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,159 out of 2,647 | 18th |
Division Manufacturing | 1,204 out of 1,447 | 17th |
Major group Chemicals And Allied Products | 714 out of 817 | 13th |
Industry group Drugs | 695 out of 783 | 11th |
Industry Pharmaceutical Preparations | 491 out of 555 | 12th |
Source: SEC filing on April 25, 2024.
Gendreau's colleagues
We found two more compensation records of executives who worked with R. Michael Gendreau at Virios Therapeutics in 2023.
News
Virios Therapeutics CEO Greg Duncan's 2023 pay falls 39% to $567K
April 25, 2024
Virios Therapeutics CEO Greg Duncan's 2022 pay slips 15% to $937K
April 27, 2023
Virios Therapeutics CEO Greg Duncan's 2021 pay falls 69% to $1.1M
April 26, 2022
Virios Therapeutics CEO Greg Duncan receives $3.5M in 2020
April 28, 2021